Table 3 Bivariate analysis of background and obstetric characteristics and uptake of five doses of SP
Characteristics | Frequency | IPTp-SP uptake | Chi-square | p value | |
|---|---|---|---|---|---|
n = 212(%) | < 5 doses n = 159 (%) | ≥5 doses n = 53 (%) | |||
Educational level | |||||
No formal education | 23 (10.8) | 22 (95.6) | 1 (4.4) | – | 0.019* |
Formal education | 189 (89.2) | 137 (72.5) | 52 (27.5) | ||
Gestational age at first ANC | |||||
First trimester | 91 (42.9) | 55 (60.4) | 36 (39.6) | ||
Second & third trimester | 121 (57.1) | 104 (85.9) | 17 (14.1) | 18.028 | < 0.001 |
Gestational age at first dose of SP | |||||
Second trimester | 194 (91.5) | 142 (73.2) | 52 (26.8) | ||
Third trimester | 18 (8.5) | 17 (94.4) | 1 (5.6) | – | 0.049* |
Side effects of SP | |||||
Side effects | 115 (54.3) | 93 (80.9) | 22 (19.1) | 4.618 | 0.032 |
No side effects | 97 (45.7) | 66 (68.0) | 31 (32.0) | ||
Reason for IPTp-SP | |||||
Malaria prevention | 171 (80.7) | 123 (71.9) | 48 (28.1) | ||
Do not know | 41 (19.3) | 36 (87.8) | 5 (12.2) | – | 0.044* |
Interval between SP doses | |||||
Monthly | 188 (88.7) | 136 (72.3) | 52 (27.7) | ||
Does not know | 24 (11.3) | 23 (95.8) | 1 (4.2) | – | 0.011* |
Number of ANC visits | |||||
≥ 4 | 188 (88.7) | 135 (71.8) | 53 (28.2) | – | 0.001* |
< 4 | 24 (11.3) | 24 (100.0) | 0 (0.0) | ||